• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Collegium Pharma (NQ: COLL )

    37.92 +0.99 (+2.68%)
    Streaming Delayed Price Updated: 11:05 AM EDT, May 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 62,945
    Open 37.12
    Bid (Size) 37.87 (4)
    Ask (Size) 37.95 (4)
    Prev. Close 36.93
    Today's Range 37.03 - 38.08
    52wk Range 20.83 - 40.95
    Shares Outstanding 31,959,828
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +21.42%
    +21.42%
    1 Month
    -2.47%
    -2.47%
    3 Month
    +13.36%
    +13.36%
    6 Month
    +74.26%
    +74.26%
    1 Year
    +64.94%
    +64.94%

    More News

    Read More
    Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
    Via Benzinga
    Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Where Collegium Pharmaceutical Stands With Analysts
    Via Benzinga
    Recap: Collegium Pharmaceutical Q4 Earnings
    Via Benzinga
    Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Analyst Expectations For Collegium Pharmaceutical's Future
    Via Benzinga
    Why Collegium Pharmaceutical Shares Are Gaining Today
    Via Benzinga
    TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Collegium Provides 2024 Financial Guidance
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium Announces $25 Million Accelerated Share Repurchase Program
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Recap: Collegium Pharmaceutical Q3 Earnings
    Via Benzinga
    Collegium to Participate in Upcoming Investor Conferences
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium Reports Third Quarter 2023 Financial Results
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Needham Maintains Buy Rating for Collegium Pharmaceutical: Here's What You Need To Know
    Via Benzinga
    Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Collegium Announces $50 Million Accelerated Share Repurchase Program
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.